Evidence map›Paper›PMID 28408477›Full record

ReviewBiochemical Society transactions2017

Pseudoscaffolds and anchoring proteins: the difference is in the details.

Stacey Aggarwal-Howarth, John D Scott

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. The βBritish journal of pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stacey Aggarwal-HowarthHoward Hughes Medical Institute and Department of Pharmacology, University of Washington, Seattle, WA, U.S.A.
John D ScottHoward Hughes Medical Institute and Department of Pharmacology, University of Washington, Seattle, WA, U.S.A. scottjdw@u.washington.edu.

Funding

Project# 4: INTERACTIONS OF ANCHORING PROTEINS WITH THEIR TARGETSP01DK054441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1999 to 2017
$27.3M
TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
Local Signaling in Diabetic ComorbiditiesR01DK105542 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2015 to 2018
$1.4M
NIDDK NIH HHS P01 DK054441NIDDK NIH HHS R01 DK105542NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

Pseudokinases and pseudophosphatases possess the ability to bind substrates without catalyzing their modification, thereby providing a mechanism to recruit potential phosphotargets away from active enzymes. Since many of these pseudoenzymes possess other characteristics such as localization signals, separate catalytic sites, and protein-protein interaction domains, they have the capacity to influence signaling dynamics in local environments. In a similar manner, the targeting of signaling enzymes to subcellular locations by A-kinase-anchoring proteins (AKAPs) allows for precise and local control of second messenger signaling events. Here, we will discuss how pseudoenzymes form 'pseudoscaffolds' and compare and contrast this compartment-specific regulatory role with the signal organization properties of AKAPs. The mitochondria will be the focus of this review, as they are dynamic organelles that influence a broad range of cellular processes such as metabolism, ATP synthesis, and apoptosis.

Indexed as

A Kinase Anchor ProteinsAnimalsCyclic AMPHumansMitochondriaPhosphoric Monoester HydrolasesPhosphotransferasesProtein Interaction Domains and MotifsSecond Messenger SystemsA Kinase Anchor ProteinsCyclic AMPPhosphoric Monoester HydrolasesPhosphotransferasesA-kinase-anchoring proteinmitochondriapseudoscaffold

Identifiers

PMID28408477
PMCPMC5497583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.